APLT
Applied Therapeutics Inc
NASDAQ: APLT · HEALTHCARE · BIOTECHNOLOGY
$0.10
+0.00% today
Updated 2026-04-29
Market cap
$14.86M
P/E ratio
—
P/S ratio
14.86x
EPS (TTM)
$-0.10
Dividend yield
—
52W range
$0 – $2
Volume
2.7M
WallStSmart proprietary scores
27
out of 100
Grade: F
Strong Sell
Investment rating
6.3
Growth
B4.5
Quality
C2.5
Profitability
F6.7
Valuation
B3/9
Piotroski F-Score
Weak
-11.3
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$0.25
+142.72%
12-Month target
—
—
Intrinsic (DCF)
$0.28
Margin of safety
+63.21%
Price chart
X-Ray snapshot
Strengths
+ Revenue growth 720.00% QoQ
+ 63.21% below intrinsic value
+ Debt/equity -4.46x — low leverage
Risks
- Piotroski 3/9 — weak financial health
- Altman Z -11.31 — distress zone
- Thin margins at 0.00%
- Negative free cash flow $-18.40M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $10.66M | $9.99M | $455000.00 | $1.00M |
| Net income | $-104.61M | $-82.51M | $-119.76M | $-105.62M | $-18.99M |
| EPS | — | — | — | — | $-0.10 |
| Free cash flow | $-90.73M | $-78.09M | $-55.17M | $-84.31M | $-18.40M |
| Profit margin | — | -774.00% | -1,198.47% | -23,214.07% | — |
Peer comparison
Smart narrative
Applied Therapeutics Inc trades at $0.10. Our Smart Value Score of 27/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of -11.31, it sits in the distress. TTM revenue stands at $1.00M. Our DCF model estimates intrinsic value at $0.28.
Frequently asked questions
What is Applied Therapeutics Inc's stock price?
Applied Therapeutics Inc (APLT) trades at $0.10.
Is Applied Therapeutics Inc overvalued?
Smart Value Score 27/100 (Grade F, Strong Sell). DCF value $0.28.
What is the price target of Applied Therapeutics Inc (APLT)?
The analyst target price is $0.25, representing +142.7% upside from the current price of $0.10.
What is the intrinsic value of Applied Therapeutics Inc (APLT)?
Based on our DCF model, intrinsic value is $0.28, a +63.2% margin of safety versus $0.10.
What is Applied Therapeutics Inc's revenue?
TTM revenue is $1.00M.
Piotroski F-Score?
3/9 — weak financial health.
Altman Z-Score?
-11.31 — distress.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio14.86x
ROE-680.00%
Beta2.08
50D MA$0.15
200D MA$0.46
Shares out0.14B
Float0.12B
Short ratio—
Avg volume2.7M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—